A carregar...
Association of adjuvant aromatase inhibitor with cataract risk in postmenopausal women with breast cancer
BACKGROUND: Aromatase inhibitor (AI) is a cornerstone drug for endocrine therapy of postmenopausal hormone receptor-positive breast cancer. The relationship between AI medication and subsequent cataract risk is yet inconclusive. METHODS: A total of 1,697 postmenopausal, early-staged, and hormone rec...
Na minha lista:
| Publicado no: | Ann Transl Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7186723/ https://ncbi.nlm.nih.gov/pubmed/32355786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.02.112 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|